chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2022 at 12:58 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Feb-2022 at 12:58 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  On 19-Feb-2022 at 12:58:56, patient received an expired booster dose.  Treatment information was not provided.   This case was linked to MOD-2022-542869 (Patient Link).
Patient requested Moderna Bivalent Covid Vaccine, recommended dosage should be 0.5 ml for this vaccine. Patient was given Moderna Covid vaccine. The recommended booster dosage for the vaccine is 0.25 ml.
11/22/2009-Phone Note: H1N1 mist given, now with fever. Telephone call received from parent with the following information: received the H1N1 mist by clinic visiting nurses yesterday, and today has temp to 102, runny nose, cough and abdominal pain. Not eating as much as usual. Eyes are watery and red. Mom already received vaccine but younger sibling didn't. Fever and flu advice given. Will f/up with me if not improving.
On Wednesday AM after Monday PM injection, patient awoke with numbness and tingling down whole right (injected) arm. Mild bruising but no erythema or swelling. paresthesia is positional and  has improved slightly as the day progresses
pt recv vax 12MAR96 & mom reported that on 30MAR96 18 days p/vax pt had a febrile sz while the family was traveling,was taken to an unk ER where temp was 104;mom states pt had devel a rash a few days prior to this event;pt treated @ ER
The pt came to the clinic on 8/27/01 with red swollen and warm left deltoid. The child was taken to the ER.
Patient noted swelling, redness and tenderness of left deltoid area evening of injection.  Erythema measures 9 cm X 13 cm.  No improvement since onset on reaction.
Patient c/o pain and swelling of Right deltoid on 9/10/2005 and stated she had vomited. Continued to complain and developed fever, was transported to ER and diagnosed with cellulitis. Related to TD injection. Prescribed Keflex 500mg, 1 po tid X 10 d. Sent to hosp on 9/12/2005. Still under care of MD. Right deltoid swollen, red, hot to touch; fever with reported vomiting. 9/20/2005 No redness or swelling of right deltoid as reported by Red Cross nurse.
This case was reported by a consumer and described the occurrence of diarrhea in a 2-month-old female subject who was vaccinated with ROTARIX, GlaxoSmithKline. A physician or other health care professional has not verified this report. Previous and/ or concurrent vaccination included DTPA-POLIO-HIB (non-GSK) (non-GSK manufacturer given on an unspecified date; Hepatitis B vaccine recombinant; manufacturer unspecified given on an unspecified date; Pneumococcal vaccines (non-GSK) ; non-GSK manufacturer given on an unspecified date. On an unspecified date the subject received unspecified dose of ROTARIX (oral). At an unspecified time after vaccination with ROTARIX, the subject experienced diarrhea. At the time of reporting the outcome of the event was unspecified. Please see case A0798920A for additional case of diarrhea with ROTARIX reported by the consumer.
Pt arrived for Booster today, she previously had Pfizer and opted to receive Moderna  Booster.  !0 Minutes after receiving the Moderna Booster pt co of burning and itching feeling running down her R arm. Cool paper towels were applied while ambulance was called. Bp143/95,  hr 105 , Spo2 , 99.   Gave water and applied cool towels to affected areas until EMS arrived. Pt received Epinephrine 0.3 mg, diphenhydramine 100mg, methylprednisolone 40mg, and fluids en route to ED. In ED, received additional 80mg of methylprednisolone and famotidine 20mg. She reportedly had urticaria, by the time of ED provider evaluation there was no urticaria, no wheezing, no shortness of breath or angioedema.
She has a history of "severe allergic reaction to the PCN family" - so she took a Benadryl 25 mg prior to receiving the vaccine on 1/15/21.  About 15 minutes later she noticed pins and needles sensation on the left side of her face and "in my left ear", denies rash/hives/throat tightness/angioedema/respiratory distress/etc.  Patient states it lasted "for awhile" was mild and never evolved into anything more serious.  However after I asked her about any other symptoms she states the left side of her face is still numb to a "very mild extent".
Area of injection, swollen, red and warm to touch, minimally tender RIGHT UPPER ARM.
L arm pain, L chest pain, L axillary lymphadenopathy- ER visit. minor symptoms.
the right arm is a little itchy and she is icing it now; feeling knocked out and tired; felt jittery; having an allergic reaction/three huge hives; the right arm was getting swollen; feeling lousy all over; right arm got tender, the pain was to the point that if the sheet brushed the area it was excruciating; the "TYLENOL was not working".; she did not sleep; arm is redish; This spontaneous report has been received from a 65 years old female patient, referring to herself. The patient's pertinent medical history included irritable bowel syndrome (IBS) and thyroid nodules. The patient was allergic to shrimp, lobster, crab and crayfish. The patient's concomitant therapies included loratadine, generic bupropion hydrochloride (WELLBUTRIN), pantoprazole, duloxetine hydrochloride, almotriptan malate (AXERT) and valacyclovir hydrochloride (VALTREX).   On 21-MAY-2020 (Thursday), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # S036811 with 02-AUG-2021; formulation vial, route, strength and dose were unknown) shot in her right arm (for the first time) for prophylaxis and a zoster rge vaccine (mammalian) (SHINGRIX) shot in her left arm.   On 22-MAY-2020 (Friday), the patient's right arm got tender and on the night the pain was to the point that if the sheet brushed the area it (the pain) was excruciating and the patient did not sleep (insomnia). On the same day (Friday night), the patient took acetaminophen (TYLENOL) (dose, strength, route, frequency, indication, lot number and expiration date were unknown). The patient stated the acetaminophen (TYLENOL) was not working (drug ineffective). On 23-MAY-2020 (Saturday morning), the patient took meloxicam. On the same day, the patient called the physician as she was feeling lousy all over and later in the day the right arm was getting swollen (peripheral swelling) and she took sulfamethoxazole (+) trimethoprim on the night. On 24-MAY-2020 (Sunday), the patient stated that she looked in the mirror and there were three huge hives. The patient stated she called the physician who told her to take diphenhydramine hydrochloride (BENADRYL) as the physician felt the patient was having an allergic reaction. On the same day, the patient took diphenhydramine hydrochloride (BENADRYL) and felt jittery afterwards. On 25-MAY-2020 (Monday) and 26-MAY-2020 (Tuesday), the patient took diphenhydramine hydrochloride (BENADRYL).  On 26-MAY-2020, the patient saw her physician. On 27-MAY-2020, the patient's arm was not as red as yesterday and the swelling had gone down. On the same day, the patient stated she was feeling knocked out and tired, the right arm was a little itchy. On an unknown date in May 2020, the patient received unspecified blood work which results were not provided. The outcome of drug ineffective and insomnia was unknown. The outcome of peripheral swelling was reported as recovering. The outcome of the other events was reported as not recovered. The causality assessment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the events was unknown.
While administering  the first dose of the Pfizer covid-19 vaccine to the patient some of the vaccine squirted in my eye (administrator's eye) at the point where needle is attached to the syringe. This could have possibly happened due to the needle not being firmly attached to the syringe. Steps will be taken in the future to make sure that needle is attached to well to the syringe. Clinical department was informed and determined that there is no need to revaccinate the patient with the first dose. Incident report, VARS report and adverse reaction report are being completed for this incident.
Information has been received from a physician concerning a 5 year old female with no allergies and no medical history who on 08-APR-2003 was vaccinated with a 0.5ml subcutaneous dose in the right leg of MMR (Enders-Edmonston, Jeryl Lynn, Wistar RA 27/3) (Lot #644234/0925M).  "Two weeks after the administration of the vaccine", on approximately 22-APR-2003, the patient developed a rash and fever. Subsequently, the patient recovered.  No other details were provided at the time of this report.  Unspecified medical attention was sought.  No product quality complaint was involved. Additional information has been requested.
LIGHT HEADED; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, once a total administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced light headed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of light headed was not reported. This report was non-serious.
It has been 4 months since the last shot . If I have to describe the pain I would describe it as pain muscle; This is a spontaneous report from a contactable consumer reporting for herself  A 42-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at the age of 42 years as DOSE 2, SINGLE for covid-19 immunisation. Historical Vaccine dose 1 of bnt162b2 for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient reported that "it has been 4 months since the last shot . if I have to describe the pain I would describe it as pain muscle (medically significant) on 2021 with outcome of unknown.   The lot number for the vaccine, [Pfizer Covid-19 Vaccine], was not provided and will be requested during follow up.
Pt vaccinated with DT/PROHIBIT/OPV mom states child had fever >104. Unable to be seen in clinic taken to ER temp 102.8.
Patient received the small pox vaccine from an expired vial. Vial was reconstituted in May and the vaccine was administered on July 14, 2018.
One day post vax, this pt developed injection site reaction with redness, swelling and induration. Treated with Benadryl and an unspecified steroid and recovered.
Had varicella 11/25/97, developed 10-15 spots on 07/17/02.
Patient has a painful lump that is sore and red where the immunization was administered intramuscularly.
motion sickness; Chills; Slight fever; Tiredness; Weakness; Flu like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received second dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the left arm as a single dose on 13Mar2021 at 11:00 (at the age of 32-year-old) for COVID-19 immunisation. The medical history and concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 6198), via an unspecified route of administration in the left arm on 20Feb2021 at 11:00, as a single dose for COVID-19 immunisation. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Laboratory test included nasal swab on early March (for work) and the result was not provided. On 13Mar2021, the patient experienced mild flu like symptoms. On 15Mar2021, the patient experienced chills, slight fever, tiredness and weakness. On 15Mar2021 at 09:45, he had motion sickness while driving to a worksite (highway driving). The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the reported events flu like symptoms, chills, slight fever, tiredness, weakness and motion sickness were recovered on an unknown date in Mar2021.   No follow-up attempts possible. No further information expected.
received their first dose of Shingrix 3 years ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date, 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter was inquiring if the patient should receive second dose now or restart the series.  The reporter did not consent to follow-up. No additional details provided by reporter.
This spontaneous report was received regarding a 54 years old female patient. On 30-DEC-2012, the patient was vaccinated in the left arm with one dose of live ZOSTAVAX(lot#,dose and route not reported). Concomitant medications included LIPITOR. On 03-JAN-2013, the patient experienced little swelling at the site of injection, needles sensation on her arm where the shot was given and sensation on her forearm. No treatment was given. The outcome of sensation on her forearm, little swelling at the site of injection, needles sensation of her arm where the shot was given and sensation of her forearm was unknown for live ZOSTAVAX. Additional information has been requested.
Pfizer dose 1 received 12/18/20 via left deltoid. 12/19/20 the injection site had a half dollar size of redness and edema and was warm to touch. 12/20/20 the edema decreased by half and became itchy like a mosquito bite. 12/22/20 redness barely noticeable at left deltoid. Still warm to touch and indurated.
reduction in taste and smell; reduction in taste and smell; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old male patient received BNT162b2 (BNT162B2), on 05Apr2021 as dose 1, single (Lot number: ER8733) at the age of 36 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies Peanuts" (unspecified if ongoing); "known allergies legumes" (unspecified if ongoing); "known allergies nuts" (unspecified if ongoing); "known allergies peas" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HYPOGEUSIA (non-serious), PAROSMIA (non-serious) all with onset 19Apr2021, outcome "not recovered" and all described as "reduction in taste and smell". The events "reduction in taste and smell" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypogeusia, parosmia.  Additional Information: The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. The patient did not have Covid prior to vaccination. Two weeks after first dose, the patient began to notice reduction in taste and smell. The loss had increased. The patient's Otolaryngologist has ruled out polyps and nasal obstructions via a CT-Scan and an MRI. The patient received treatment with nasal steroid rinses. The patient had 3 additional Pfizer COVID vaccines. The patient received Dose 2, lot number: EW0169, Date: 26Apr2021, Anatomical location: Right arm. The patient received Dose 3 (BOOSTER), lot number: FJ8762, Date: 28Nov2021, Anatomical location: Right arm. The patient recently received Dose 4, lot number: GH9694, Date: 12Sep2022, Time: 04:15 PM, Anatomical location: Right arm. Post vaccination, the patient had COVID test and was found negative. The patient never contracted COVID and believe he was never been asymptomatic.
Felt weak in her legs/ Legs are still weak; "Was speaking like she took a sleeping pill"; Dizzy for 2 weeks; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Felt weak in her legs/ Legs are still weak), FEELING ABNORMAL ("Was speaking like she took a sleeping pill"), DIZZINESS (Dizzy for 2 weeks) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced MUSCULAR WEAKNESS (Felt weak in her legs/ Legs are still weak), FEELING ABNORMAL ("Was speaking like she took a sleeping pill"), DIZZINESS (Dizzy for 2 weeks) and CHILLS (Chills). At the time of the report, MUSCULAR WEAKNESS (Felt weak in her legs/ Legs are still weak) had not resolved and FEELING ABNORMAL ("Was speaking like she took a sleeping pill"), DIZZINESS (Dizzy for 2 weeks) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
On days 2 and 3 post vaccination, she experienced chills and body ache, which was resolved by day 5 post vaccination, when she developed symmetric dyesthesia (hot sensation) in both her legs, beginning in the foot and calves, and slowly extending upward to her mid thighs over several hours. No weakness, pain, numbness or tingling in any part of her body, including area affected by paresthesia.   By day 7 post vaccination, the dyesthesia had receded back to both calves and feet, and by day 8 had fully resolved except for a small patch of dyesthesia over several inch area of side of right foot.
Redness, pain, and swelling at site. Swelling and induration 3 inches x 5 inches.
The pt experienced a local reaction measuring 2.5 x 1.25" on the left leg. Reaction not noted until approximately 14 hours post vax. The pt also experienced a fever of 99.6 up to 101. Pt was treated with Keflex.
Beginning in February of 2021 I began experiencing intense body pain. I was having so much pain on my body I could not explain what was going on to the doc. at the medical center. I was unable to lift my arms. In July I was unable to lift my grandbaby. I saw the doctor again and was prescribe oxycodone to help with pain. I was unable to sleep. I couldn't do much at all and my bicep muscle actually broke as shown on the ultrasound. My two legs, I kept falling. I continue to work because I don't want to lose my job. I have fallen down my stairs. I have to use a walker. My knees are swollen. I am a nurse and I work 12 hour shifts. The meds do not work and I chose I different doctor, and duloxetine.
On 8-18-13 staring spells with apnea, cyanosis, limp, irreg breathing to ER per ambulance - admitted with likely seizure. CSF glucose decreased at 34 while serum 7100. Episode captured on video EEG. Awaiting test results for GLUT 1. Home with pulse ox. No medication.
sore throat; muscle aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Sep2021 17:30 (Lot number: FF2588) at the age of 69 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 27Sep2021 21:00, outcome "recovering", described as "sore throat"; MYALGIA (non-serious) with onset 27Sep2021 21:00, outcome "recovering", described as "muscle aches". Therapeutic measures were not taken as a result of oropharyngeal pain, myalgia.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient came in for Pfizer third dose booster and the nurse, confused about the Booster guider between Pfizer and Moderna , offered the patient Moderna Booster instead of Moderna. Patient is only 17 years old.
Vaccine administered - became pale, week Sats 87%-88%, Heart rate 60-70, BP 82/40.  Administered epipen and transported to ER with O2.  Fluids given at ER Solumed rol, Solu certef.  06/04/2007 MR received for ER visit for episode of pallor after receiving hep A vaccine. O2 sats 99-100%. Pt. drowsy.  Txd with Solumedrol and Solucortef IV.  Color improved and child more interactive.  D/C home. DX: Allergic reaction to Hep A.